Detalhe da pesquisa
1.
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.
Blood
; 141(3): 295-308, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260765
2.
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.
Blood
; 138(5): 387-400, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351368
3.
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(5): 503-513, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156478
4.
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
J Natl Compr Canc Netw
; 20(2): 106-117, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130502
5.
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.
BMC Cancer
; 21(1): 510, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957901
6.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
J Natl Compr Canc Netw
; 19(1): 16-27, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406488
7.
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(6): 721-749, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200351
8.
Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine.
Nanomedicine
; 16: 217-225, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30639670
9.
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(1): 60-87, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28040720
10.
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(7): 926-957, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687581
11.
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia.
Br J Haematol
; 168(6): 796-805, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403830
12.
Myelodysplastic syndromes, version 2.2015.
J Natl Compr Canc Netw
; 13(3): 261-72, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736003
13.
Effect of a Pluronic(®) P123 formulation on the nitric oxide-generating drug JS-K.
Pharm Res
; 32(4): 1395-406, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25330743
14.
Response monitoring, tolerability, and effectiveness of imatinib treatment for chronic myeloid leukemia in a retrospective research database.
J Natl Compr Canc Netw
; 12(8): 1113-21, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099443
15.
Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRI.
Nitric Oxide
; 30: 17-25, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23370169
16.
Myelodysplastic syndromes: clinical practice guidelines in oncology.
J Natl Compr Canc Netw
; 11(7): 838-74, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847220
17.
Acute myeloid leukemia, version 2.2013.
J Natl Compr Canc Netw
; 11(9): 1047-55, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24029121
18.
How to choose frontline therapy for chronic myelogenous leukemia: so many drugs, not so many patients.
J Natl Compr Canc Netw
; 10(1): 112-8; quiz 119, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22223871
19.
Management of extramedullary leukemia as a presentation of acute myeloid leukemia.
J Natl Compr Canc Netw
; 10(9): 1165-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22956813
20.
NCCN Clinical Practice Guidelines Acute myeloid leukemia.
J Natl Compr Canc Netw
; 10(8): 984-1021, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22878824